Opinions of the General Office of the China Food and Drug Administration on Seeking Public Comments on the Announcement on Relevant Matters concerning the Drug Re-registration (Draft for Comment)
Opinions of the General Office of the China Food and Drug Administration on Seeking Public Comments on the Announcement on Relevant Matters concerning the Drug Re-registration (Draft for Comment)
Opinions of the General Office of the China Food and Drug Administration on Seeking Public Comments on the Announcement on Relevant Matters concerning the Drug Re-registration (Draft for Comment)
February 13, 2017
In order to fulfill the relevant requirements of the Opinions of the State Council on the Reform of the Evaluation and Approval System for Drugs and Medical Devices (Guo Fa [2015] No.44), the China Food and Drug Administration has drafted and issued the Announcement on Relevant Matters concerning the Drug Re-registration (Draft for Comment) for public comment.
......
February 13, 2017
In order to fulfill the relevant requirements of the Opinions of the State Council on the Reform of the Evaluation and Approval System for Drugs and Medical Devices (Guo Fa [2015] No.44), the China Food and Drug Administration has drafted and issued the Announcement on Relevant Matters concerning the Drug Re-registration (Draft for Comment) for public comment.
......